NASDAQ:ORGO
Organogenesis Holdings Inc. Class A Stock News
$2.46
+0.105 (+4.47%)
At Close: Apr 29, 2024
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
07:30am, Tuesday, 16'th Apr 2024
CANTON, Mass., April 16, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of
Why Organogenesis Holding Stock Plummeted by 18% Today
06:29pm, Friday, 01'st Mar 2024
To put it charitably, the market wasn't impressed with the company's recent performance. They traded out of the stock following the publication of quarterly and annual results.
Organogenesis Holdings, Inc. (ORGO) Q4 2023 Earnings Call Transcript
11:06pm, Thursday, 29'th Feb 2024
Organogenesis Holdings, Inc. (ORGO) Q4 2023 Earnings Call Transcript
Organogenesis (ORGO) Reports Break-Even Earnings for Q4
06:46pm, Thursday, 29'th Feb 2024
Organogenesis (ORGO) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to earnings of $0.06 per share a year ago.
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024
04:05pm, Thursday, 08'th Feb 2024
CANTON, Mass., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of p
Are You Looking for a Top Momentum Pick? Why Organogenesis (ORGO) is a Great Choice
01:32pm, Monday, 15'th Jan 2024
Does Organogenesis (ORGO) have what it takes to be a top stock pick for momentum investors? Let's find out.
Best Momentum Stocks to Buy for January 5th
11:17am, Friday, 05'th Jan 2024
ORGO, CALM and NET made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 5, 2024.
New Strong Buy Stocks for January 5th
08:16am, Friday, 05'th Jan 2024
ORGO, CALM, W, NET and EVH have been added to the Zacks Rank #1 (Strong Buy) List on January 5, 2024.
Organogenesis (ORGO) is a Great Momentum Stock: Should You Buy?
01:32pm, Thursday, 28'th Dec 2023
Does Organogenesis (ORGO) have what it takes to be a top stock pick for momentum investors? Let's find out.
5 Reasons Why Small-Cap Stocks Can Surge in 2024: 5 Top Picks
09:46am, Friday, 15'th Dec 2023
Small-cap stocks should rally ahead due to cheaper valuation, cooling inflation data and hopes of Fed rate cuts in 2024. Against this backdrop, Organogenesis (ORGO), Riskified (RSKD), Hooker Furniture
Here Is Why Bargain Hunters Would Love Fast-paced Mover Organogenesis (ORGO)
10:32am, Thursday, 30'th Nov 2023
Organogenesis (ORGO) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks t
Organogenesis Holdings, Inc. (ORGO) Q3 2023 Earnings Call Transcript
10:16pm, Thursday, 09'th Nov 2023
Organogenesis Holdings, Inc. (NASDAQ:ORGO ) Q3 2023 Earnings Conference Call November 9, 2023 5:00 PM ET Company Participants Gary Gillheeney - President, CEO & Chair David Francisco - CFO Conference
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023
07:30am, Thursday, 05'th Oct 2023
CANTON, Mass., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of p
Why Shares of Organogenesis Holdings Are Up Thursday
11:44am, Thursday, 28'th Sep 2023
Organogenesis focuses on advanced wound products. The company's second-quarter revenue and net income were down year over year.
Organogenesis Holdings Inc. to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
04:05pm, Wednesday, 06'th Sep 2023
CANTON, Mass. , Sept. 06, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of
